THE BTG BLOG > M&A

Top 3 Business Problems – Market Access

market access consultants

Having robust, nimble market access strategies is increasingly important in life sciences. It’s also increasingly challenging, with fast-changing markets, increased patient engagement, and global pricing pressures. Fortunately, Business Talent Group enables life science companies to access on-demand market access consultants to help with these challenges….

READ MORE


4 Tips for a Successful Merger Integration

merger integration: rope in a knot

Statistically speaking, most merger integrations fail—between 70% and 90%, according to McKinsey and Harvard Business Review. What’s worse, those numbers are consistent in study after study… and they haven’t budged in years. So what can companies do to reduce risk and increase their odds of…

READ MORE


Top 3 Business Problems – Post-Merger Integration

post-merger integration

Post-merger integration is risky even for the well-prepared. Today’s deals are more complex than ever, and their value is always threatened by turnover, missed targets, and misaligned priorities. So how can you be sure you’re not leaving money on the table—or, worse, undermining the hard…

READ MORE


How to Select and Use the Right Metrics in Early-Stage M&A

early-stage M&A metrics: woman with pen filling out a form looking at her phone

In the data-intensive field of early-stage M&A work, it can be daunting to decide which metrics to focus on. It’s also crucial to your ability to assess opportunities and create plans that truly capture them. So which M&A deal evaluation metrics will give you the…

READ MORE


Top 3 Business Problems – Early-Stage M&A

early stage m&a

Business Talent Group’s independent consultants can help at all stages of the M&A lifecycle, but one place where they excel is at the start of a deal—or before, as executives seek to validate growth strategies, analyze market dynamics, and understand the high-level value of an…

READ MORE


Why Big Pharma Needs to Think Small

big pharma M&A: close up of the eye of a scientist looking through a microscope

Over the past few years, the life science industry has witnessed unprecedented pharma M&A activity. Both 2015 and 2016 saw a wave of consolidation—driven largely by specialty pharma companies, which target niche markets with unmet needs. This year, the winds may be blowing in a…

READ MORE


Don’t Let Culture Kill Your Next Acquisition

culture clash; hand raised in a fist

Culture is key when it comes to completing a successful merger or acquisition. Culture integration has killed some of the biggest deals in history. And while it’s been recognized as an integral component of organizational effectiveness since the 1980s—McKinsey’s famous 7S Framework outlines four “soft”…

READ MORE


Send this to a friend